Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?

Authors

  • Andrew Thomas Medical student, Sree Gokulam Medical College and Research Foundation, Trivandrum, India https://orcid.org/0000-0002-2997-4525
  • Mohan T. Shenoy MBBS, MD, DM, Consultant Endocrinologist, Department of Endocrinology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India https://orcid.org/0000-0002-2298-8852
  • K.T. Shenoy MBBS, MD, DM, Professor and Head of department, Department of Gastroenterology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India https://orcid.org/0000-0002-2826-6869
  • Nirmal George MBBS, MD, Assistant Professor, Department of Pharmacology, Sree Gokulam Medical College and Research Foundation, Trivandrum, India

DOI:

https://doi.org/10.5195/ijms.2021.786

Keywords:

Blood Glucose Self-Monitoring, Type 2 Diabetes Mellitus, Glycemic Control, Blood glucose, Diabetes Complications

Abstract

Background: The effectiveness of self-monitoring of blood glucose (SMBG) in type 2 diabetes mellitus (T2DM) patients is debated in the literature. We aimed at elucidating the association and patterns of complications between SMBG use and plasma glucose values.

Methods: This cross-sectional study comprised 303 participants from outpatient departments with T2DM for over 12 months. We analyzed sociodemographic and clinical variables including: anthropometry, SMBG use, disease duration, treatment modality, complications, plasma glucose level, and glycated hemoglobin level (%).

Results: The mean duration of T2DM was 93 ± 76 months. Participants were grouped into SMBG users (n=115, 38%) and non-SMBG users (n=188, 62%). The mean fasting plasma glucose levels of SMBG and non-SMBG users were 140.7±42.7 (95% Confidence Interval [95%CI]: 132.72;148.67) mg/dl and 145.4±50 (95%CI: 138.12;152.67) mg/dl (p=0.03), respectively. The mean post-prandial plasma glucose levels of the SMBG and non-SMBG groups were 202 ± 63.42 (95%CI: 190.23;213.76) mg/dl and 209±84.54 (95%CI: 196.56;221.43) mg/dl (p=0.002), respectively. The mean difference in HbA1c among the groups were 8.14±1.69% (95%CI: 7.59;8.68) and 8.15±1.98% (95%CI: 7.27;9.02) (p=0.4), respectively. Hypoglycemia (n=50, 43.5%) was the most common complication. The prevalence of neuropathy (n=5, 4.3%, p=0.036) and cardiovascular disease (n=21, 18.3%, p=0.042) were significantly higher in the SMBG group.

Conclusion: Although plasma glucose values were significantly lower in the SMBG group, its clinical significance remains questionable. Furthermore, many participants in both groups had shortfalls in awareness, monitoring, and glycemic control. SMBG use needs to be evaluated in a cohort of patients with T2DM with adequate health awareness.

Metrics

Metrics Loading ...

References

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J. 2014 Jan 31;7(1):45–8.

Colagiuri S, Sandbaek A, Carstensen B, Christensen J, Glumer C, Lauritzen T, et al.Comparability of venous and capillary glucose measurements in blood. Diabet Med. 2003 Nov;20(11):953-6.

Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, et al. HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes. 2011 Jul;5(2):95-102.

Thomas T, Prabhata S, Valsangkar S. Diabetes screening and the distribution of blood glucose levels in rural areas of North India. J Family Community Med. 2015 Sep-Dec;22(3):140-4.

Mohan V, Mapari J, Karnad P, Mann J, Maheshwari V. Reduced diabetes mellitus-related comorbidities by regular self-monitoring of blood glucose: Economic and quality of life implications. Indian J Endocr Metab. 2018;22(4):461.

Malanda UL, Bot SD, Nijpels G. Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence. Diabetes Care. 2013 Jan 1;36(1):176–8.

AADE7™ Self-Care Behaviors. American Association of Diabetes Educators (AADE) Position Statement. 2014. Available from: https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/publications/aade7_position_statement_final.pdf?sfvrsn=4. Last updated December 03, 2014; cited Jun 29, 2019.

Ceriello A, Monnier L, Owens D. Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol. 2019 Mar;7(3):221-230.

Young LA, Buse JB, Weaver MA, Vu MB, Mitchell CM, Blakeney T et al. Glucose Self-Monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial. JAMA Intern Med. 2017 Jan;177(7):920–29.

Wang J, Zgibor J, Matthews JT, Charron-Prochownik D, Sereika SM, Siminerio L. Self-Monitoring of Blood Glucose Is Associated With Problem-Solving Skills in Hyperglycemia and Hypoglycemia. Diabetes Educ. 2021 Mar 1;38(2):207–18.

Farmer A, Balman E, Gadsby R, Moffatt J, Cradock C, McEwen L, et al. Frequency of Self-Monitoring of Blood Glucose in Patients with Type 2 Diabetes: Association with Hypoglycaemic Events. Curr Med Res Opin. 2008 Nov 1;24(11): 3097–104.

Iwuala SO, Olamoyegun MA, Sabir AA, Fasanmade OA. The relationship between self-monitoring of blood glucose and glycaemic control among patients attending an urban diabetes clinic in Nigeria. Ann Afr Med. 2015 Oct-Dec;14(4):182-7.

Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, et al. Self-Monitoring of Blood Glucose Significantly Improves Metabolic Control in Patients with Type 2 Diabetes Mellitus: The Auto-Surveillance Intervention Active (ASIA) Study. Diabetes Metab. 2003 Dec;29(6):587–94.

American Diabetes Association. Standards of medical care in diabetes. 2019. Available from https://care.diabetesjournals.org/content/diacare/suppl/2018/12/17/42.Supplement_1.DC1/DC_42_S1_2019_UPDATED.pdf. Last updated January, 2019; cited Jun 29, 2019.

Mast O, Tan A, Punjabi K. Usage of Self-Monitoring of Blood Glucose (Smbg) By Diabetes Therapy Type in India. Value Health. 2014 Nov;17(7):A362.

Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version. www.OpenEpi.com, cited Apr 24, 2019.

Heslehurst N, Sattar N, Rajasingam D, Wilkinson J, Summerbell CD, Rankin J. Existing maternal obesity guidelines may increase inequalities between ethnic groups: a national epidemiological study of 502,474 births in England. BMC Pregnancy Childbirth. 2012 Dec 18;12:156.

Ranganathan P, Pramesh CS, Buyse M. Common pitfalls in statistical analysis: Clinical versus statistical significance. Perspect Clin Res. 2015 Jul-Sep;6(3):169-70.

Monnier L, Colette C. Target for glycemic control: concentrating on glucose. Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S199-204.

Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, et al. Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group. Diabetes Technol Ther. 2014 Jul;16(7):460-75.

O'Kane MJ, Bunting B, Copeland M, Coates VE, ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ. 2008 May 24;336(7654):1174-7.

International Diabetes Federation. Fact Sheet: Diabetes and Cardiovascular Disease (CVD). Available from https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Last updated June 29, 2019; cited Jun 29, 2019.

Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, et al. ADAG Study Group. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2011 Jan;54(1):69-72.

Huang IC, Wang PW, Liu RT, Tung SC, Chen JF, Kuo MC, et al The influence of self-monitoring blood glucose frequency on the oscillation of hemoglobin A1c and chronic complications. Chang Gung Med J. 2012 Jan-Feb;35(1):46-53.

Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton AM. Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol. 2013 Mar 1;7(2):478-88.

Austin MM. Self-Monitoring of Blood Glucose in Type 2 Diabetes: Preface. Diabetes Spectrum, 2013;26(2):80–1.

Dudley JD. The diabetes educator's role in teaching the diabetic patient. Diabetes Care. 1980 Jan-Feb;3(1):127-33.

Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012 Jan 18;1:CD005060.

Schütt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):384-8.

Downloads

Published

2021-06-22

How to Cite

Thomas, A., Shenoy, M. T., Shenoy, K., & George, N. . (2021). Glucometers for Patients with Type 2 Diabetes Mellitus: Are they helpful?. International Journal of Medical Students, 9(2), 140–144. https://doi.org/10.5195/ijms.2021.786

Issue

Vol. 9 No. 2 (2021)

Section

Original Article

Categories

License

  1. The Author retains copyright in the Work, where the term “Work” shall include all digital objects that may result in subsequent electronic publication or distribution.
  2. Upon acceptance of the Work, the author shall grant to the Publisher the right of first publication of the Work.
  3. The Author shall grant to the Publisher and its agents the nonexclusive perpetual right and license to publish, archive, and make accessible the Work in whole or in part in all forms of media now or hereafter known under a Creative Commons Attribution 4.0 International License or its equivalent, which, for the avoidance of doubt, allows others to copy, distribute, and transmit the Work under the following conditions:
    1. Attribution—other users must attribute the Work in the manner specified by the author as indicated on the journal Web site; with the understanding that the above condition can be waived with permission from the Author and that where the Work or any of its elements is in the public domain under applicable law, that status is in no way affected by the license.
    2. The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgment of its initial publication in this journal.
    3. Authors are permitted and encouraged to post online a prepublication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. Any such posting made before acceptance and publication of the Work shall be updated upon publication to include a reference to the Publisher-assigned DOI (Digital Object Identifier) and a link to the online abstract for the final published Work in the Journal.
    4. Upon Publisher’s request, the Author agrees to furnish promptly to Publisher, at the Author’s own expense, written evidence of the permissions, licenses, and consents for use of third-party material included within the Work, except as determined by Publisher to be covered by the principles of Fair Use.
    5. The Author represents and warrants that:
      1. the Work is the Author’s original work;
      2. the Author has not transferred, and will not transfer, exclusive rights in the Work to any third party;
      3. the Work is not pending review or under consideration by another publisher;
      4. the Work has not previously been published;
      5. the Work contains no misrepresentation or infringement of the Work or property of other authors or third parties; and
      6. the Work contains no libel, invasion of privacy, or other unlawful matter.
    6. The Author agrees to indemnify and hold Publisher harmless from the Author’s breach of the representations and warranties contained in Paragraph 6 above, as well as any claim or proceeding relating to Publisher’s use and publication of any content contained in the Work, including third-party content.

Enforcement of copyright

The IJMS takes the protection of copyright very seriously.

If the IJMS discovers that you have used its copyright materials in contravention of the license above, the IJMS may bring legal proceedings against you seeking reparation and an injunction to stop you using those materials. You could also be ordered to pay legal costs.

If you become aware of any use of the IJMS' copyright materials that contravenes or may contravene the license above, please report this by email to contact@ijms.org

 

Infringing material

If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to contact@ijms.org

Most read articles by the same author(s)